Hyaluronic Acid Binding Peptide-Polymer System for Joint Lubrication
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clinical strategies for enhancing tissue lubrication, such as HA injections, are ineffective due to rapid clearance and limited retention of lubricants in tissues like joints, leading to inadequate joint health and lubrication, particularly in osteoarthritis.
Innovation Solution
A biomaterial approach using a synthetic peptide-polymer system to non-covalently bind HA to the tissue surface, creating a self-healing coating that enhances lubrication and retains HA, mimicking the role of lubricin and providing physical and biological benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If HA is injected into the joint to improve synovial lubrication, then the lubrication function is temporarily enhanced, but the HA is rapidly cleared and turnover occurs quickly, leading to short duration of action
Solution Approach 1:
The patent introduces HA-binding peptides as intermediary molecules that mediate between the injected HA and the joint tissue surface. These peptides bind to HA and anchor it to the tissue, preventing rapid clearance and extending retention time while maintaining lubrication function.
Solution Approach 2:
The patent extracts and utilizes specific binding domains (HA-binding peptides) from larger proteins and incorporates them into a peptide-polymer system. This extracted functional element selectively binds HA and enables targeted retention at the joint surface without requiring the entire native protein structure.
2Reliability
If HA is injected to enhance lubrication, then the lubrication effect is achieved, but the injection requires precise targeting of areas needing lubrication which is difficult to accomplish
Solution Approach 1:
The HA-binding peptides act as intermediaries that passively target the joint tissue surface through their natural affinity for the extracellular matrix components at the cartilage surface. This eliminates the need for active targeting mechanisms or precise injection positioning, as the peptides automatically guide HA to the appropriate location.
Solution Approach 2:
The peptide-polymer system performs self-targeting by utilizing the inherent binding properties of the HA-binding peptides for extracellular matrix components at the joint surface. The system automatically localizes to the tissue surface without requiring external guidance or precise surgical intervention.
3Reliability
If therapeutic strategies focus only on replacing or enhancing the lubricant in the fluid phase, then the lubrication is temporarily improved, but the tissue surface remains unprotected and the effect is short-lived
Solution Approach 1:
The patent applies HA-binding peptides to the tissue surface in advance to create a binding layer before HA injection. This preliminary action prepares the surface to immediately capture and retain HA, extending the duration of both lubrication and surface protection effects.
Solution Approach 2:
The HA-binding peptides serve as intermediaries that bridge the lubricant (HA) and the tissue surface, creating a stable interface that simultaneously provides lubrication enhancement and surface protection. This intermediary layer prevents direct contact between HA and the surface while maintaining the lubrication effect.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The HA-binding peptide-polymer system effectively improves boundary lubrication, reduces friction, and prolongs the retention of HA, offering a stable and sustained lubrication solution for joint health, even in diseased states like osteoarthritis, and can be applied to various tissues including the eyes and pleural cavity.
Implementation Method 1
A biomaterial approach using a synthetic peptide-polymer system to non-covalently bind HA to the tissue surface
Implementation Method 2
improves boundary lubrication, reduces friction
Data Source
AI summary
The present invention provides novel biomaterial compositions and methods having a technology to improve retention of hyaluronic acid (HA). The biomaterial compositions utilize small HA binding peptides and extracellular matrix binding (ECM) peptides that are tethered to synthetic biocompatible polymers. When tethered to the polymers, the peptide region allows the polymers to bind to HA and to tissues such as cartilage. The novel biomaterial compositions can be used to coat or chemically modify cartilage or tissues with a biologically compatible polymer having HA binding peptides, which allow HA to bind to the surface of the cartilage or tissues. Methods of using same are also provided.